Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the central nervous system (CNS), and Panaxia (TASE: PNAX), a global pharmaceutical company that develops, manufactures and...
Dr. Dadi Segal, CEO of Panaxia Global, said, “After obtaining a marketing permit in Germany, which was a very significant milestone for us, we are proud to...
Panaxia Labs Israel, Ltd. (Panaxia Israel) (TASE: PNAX), Israel’s leading medical cannabis products manufacturer and Leriva Group, one of Greece’s leading distributors of medical equipment, medical supplies and health services, announced today, Wednesday...
Panaxia Global, the controlling owner of Panaxia Labs Israel Ltd. (“Panaxia Israel”), (TASE: PNAX), Israel’s largest manufacturer of medical cannabis products, and its partner, Neuraxpharm, Europe’s leading pharmaceutical company specialized in...